Aug 2026
The efficacy and safety of omadacycline plus β-lactam versus moxifloxacin plus β-lactam for the treatment of severe community-acquired pneumonia: study protocol of a multicenter, prospective, randomized controlled non-inferiority trial.
Xin Zhang, Dan-yang She, Yinghui Shi et al.
· Infection · 0 citations